slotkoers
Andere beurzen
|
||
- GBX | - |
02/05 | Sectorupdate: Aandelen gezondheidszorg eind van de middag zachter | MT |
02/05 | Sectorupdate: Aandelen gezondheidszorg trekken donderdagmiddag terug | MT |
Omzet 2024 * | 48,96 mld. 45,49 mld. | Omzet 2025 * | 50,79 mld. 47,2 mld. | Marktkapitalisatie | 198 mld. 184 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 10,29 mld. 9,56 mld. | Nettowinst (verlies) 2025 * | 12,05 mld. 11,2 mld. | EV/omzet 2024 * | 4,32 x |
Nettoschuld 2024 * | 12,88 mld. 11,97 mld. | Nettoschuld 2025 * | 11,28 mld. 10,48 mld. | EV/omzet 2025 * | 4,13 x |
K/w-verhouding 2024 * |
19,3
x | K/w-verhouding 2025 * |
16,5
x | Werknemers | - |
Dividendrendement 2024 * |
3,71% | Dividendrendement 2025 * |
3,85% | Vrij verhandelbaar | 85,22% |
Recentste transcriptie over NOVARTIS
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 48 | 01-01-05 | |
Director of Finance/CFO | 59 | 01-01-03 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 16-05-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 01-01-13 |
Simon Moroney
BRD | Director/Board Member | 65 | 28-02-20 |
Chairman | 68 | 01-01-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,08% | 662 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
-11,12% | 194 mld. | |
-3,40% | 157 mld. | |
+8,08% | 167 mld. |
- Beurs
- Aandelen
- Koers NOVN
- Koers 0HKE